Remedee Labs' Solution becomes the first CE marked medical device (class IIa) approved for the treatment of fibromyalgia in Europe

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Remedee-Labs-Medical

More Like This

PR Newswire associated0

Amicomed by Newel Health obtains EU MDR certification as a digital medical device for hypertension management

PR Newswire associated0

Theranica Enters Into Agreement With Dr. Reddy's for Commercializing Nerivio® in Europe

PR Newswire associated0

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation

PR Newswire associated0

Neurolief Announces Breakthrough Results from Pivotal Clinical Trial of Brain Neuromodulation System for Treating Major Depressive Disorder

EpiMonitor is a medical-grade wearable solution for people living with epilepsy. Designed for daily life, it combines night & day, high-accuracy seizure monitoring with comprehensive health tracking. It is the only wrist-worn device and companion app combination fully cleared by the FDA for epilepsy monitoring.

Empatica Achieves CE MDR Certification for EpiMonitor, Bringing Round-the-Clock Epilepsy Monitoring to Europe

PR Newswire associated0

Morphic Medical Announces CE Mark for RESET® Endoscopic Device Therapy

RegenLab France receives prestigious EU-EIB Innovation Champion Award. Antoine Turzi, CEO and Founder of RegenLab, pictured between two officials of the European Investment Bank. (Photo: Business Wire)

RegenLab France Receives Prestigious EU-EIB Innovation Champion Award

Gedeon Richter: Medical Treatment of Endometriosis with a progressive approach